许可

This profile gathers the share dealings of 许可 in 易明医药, where the filings describe the role as senior executive. We count 3 filings; the first trade dates from 28 April 2025 and the latest from 7 May 2025.

No open-market purchase appears, only 3 sales worth €164k.

On 7 May 2025 came the latest disclosure, an open-market sale for €144k in 易明医药. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.